 |
Code of Federal Regulations (Last Updated: November 8, 2024) |
 |
Title 21 - Food and Drugs |
|
|
Chapter I - Food and Drug Administration, Department of Health and Human Services |
|
|
SubChapter C - Drugs: General |
|
|
Part 250 - Special Requirements for Specific Human Drugs |
| Subpart A - Drugs Regarded as Misbranded |
| § 250.11 - Thyroid-containing drug preparations intended for treatment of obesity in humans. |
| § 250.12 - Stramonium preparations labeled with directions for use in self-medication regarded as misbranded. |
| Subpart B - New Drug or Prescription Status of Specific Drugs |
| § 250.100 - Amyl nitrite inhalant as a prescription drug for human use. |
| § 250.101 - Amphetamine and methamphetamine inhalers regarded as prescription drugs. |
| § 250.102 - Drug preparations intended for human use containing certain “coronary vasodilators”. |
| § 250.105 - Gelsemium-containing preparations regarded as prescription drugs. |
| § 250.108 - Potassium permanganate preparations as prescription drugs. |
| §§ 250.103--250.104 - [Reserved] |
| §§ 250.106--250.107 - [Reserved] |
| Subpart C - Requirements for Drugs and Foods |
| § 250.201 - Preparations for the treatment of pernicious anemia. |
| Subpart D - Requirements for Drugs and Cosmetics |
| § 250.250 - Hexachlorophene, as a component of drug and cosmetic products. |